Company Filing History:
Years Active: 2021-2024
Title: The Innovative Contributions of Mark S. Egler
Introduction
Mark S. Egler, based in Reading, Massachusetts, has established himself as an impactful inventor in the medical technology field. With two patents to his name, he is known for his work with advanced blood pump systems that enhance the functionality and efficiency of implantable medical devices.
Latest Patents
Among his notable inventions is a patented method for operating an implantable blood pump. This innovative blood pump features a first stator, a second stator, and an impeller that is movably disposed between the two. The method entails applying a first voltage waveform to the first stator to generate a magnetic field capable of rotating the impeller. Additionally, a second voltage waveform, phase-shifted from the first, is applied to the second stator, producing an asymmetric effect that aids in the rotation of the impeller. This dual-phase approach offers significant advancements in the performance of blood pumps, potentially improving patient outcomes in cardiac care.
Career Highlights
Mark works with HeartWare, Inc., a prominent company in the field of medical devices, particularly known for its innovative heart pump technologies. His role there allows him to leverage his expertise to develop next-generation medical solutions aimed at treating heart diseases.
Collaborations
Throughout his career, Mark has collaborated with talented professionals, including Fernando Casas and Carlos Reyes. These collaborations highlight the importance of teamwork in advancing technology and innovation in the medical field, emphasizing the collaborative spirit that drives successful invention.
Conclusion
Mark S. Egler’s contributions to the realm of implantable blood pumps mark significant achievements in medical technology. His innovative methods and collaborative efforts not only reflect his technical expertise but also represent the collective advancement in heart health solutions. As he continues to contribute to HeartWare, Inc., the field of medical devices can look forward to ongoing advancements that may greatly enhance patient care.